CL2A-SN-38 is a cleavable linker-based antibody-drug conjugate (ADC) containing the topoisomerase I inhibitor SN-38 (Item No. 15632) and a maleimidocaproyl linker.{57624} CL2A-SN-38 has been linked to tumor-selective humanized antibodies, such as anti-T
库存:
25 mg, 5 mg
供应商:
Cayman
An antibody-drug conjugate containing SN-38; cytotoxic to various cancer cells when linked to hRS7; reduces tumor growth in BxPC-3 pancreatic and SK-MES-1 lung cancer mouse xenograft models when linked to hRS7